
Psychiatr Serv 51:210-215, February 2000
© 2000 American Psychiatric Association
Shorter Hospital Stays and More Rapid Improvement Among Patients With Schizophrenia and Substance Disorders
Richard K. Ries, M.D.,
Joan Russo, Ph.D.,
Dane Wingerson, M.D.,
Mark Snowden, M.D.,
Katherine A. Comtois, Ph.D.,
Debra Srebnik, Ph.D. and
Peter Roy-Byrne, M.D.
OBJECTIVE: Length of stay and treatment response of inpatients with acute schizophrenia were examined to determine whether differences existed between those with and without comorbid substance-related problems. METHODS: The sample comprised 608 patients with a diagnosis of schizophrenia or schizoaffective disorder treated on hospital units with integrated dual diagnosis treatment. They were rated on admission and discharge by a psychiatrist using a structured clinical instrument. Patients with no substance-related problems were compared with those with moderate to severe problems using t tests, chi square tests, and analysis of variance. RESULTS: When analyses controlled for age, gender, and other clinical variables, dually diagnosed patients were found to have improved markedly faster compared with patients without a dual diagnosis. Their hospital stays were 30 percent shorter on both voluntary and involuntary units. They also showed somewhat greater symptomatic improvement and no increase in 18-month readmission rates. On admission the dual diagnosis group was more likely to be younger, male, and homeless and more likely to be a danger to self and others. Severity of psychosis was the same at admission for the two groups, but the dually diagnosed patients were rated as less psychotic at discharge. CONCLUSIONS: Dually diagnosed patients with schizophrenia appear to stabilize faster during acute hospitalization than those without a dual diagnosis. The authors hypothesize that substance abuse may temporarily amplify symptoms or that these patients may have a higher prevalence of better-prognosis schizophrenia. The availability of integrated dual-focus inpatient treatment and a well-developed outpatient system may also have helped these patients recover more rapidly.
This article has been cited by other articles:

|
 |

|
 |
 
D. Capdevielle and K. Ritchie
The long and the short of it: are shorter periods of hospitalisation beneficial?
The British Journal of Psychiatry,
March 1, 2008;
192(3):
164 - 165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Marcus and M. Olfson
Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
Schizophr Bull,
January 1, 2008;
34(1):
173 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dickey, S.-L. T. Normand, R. Drake, R. D. Weiss, H. Azeni, and A. Hanson
Limiting Inpatient Substance Use Treatment: What are the Consequences?
Med Care Res Rev,
September 1, 2003;
60(3):
332 - 346.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Frankle, D. Shera, H. Berger-Hershkowitz, A. E. Evins, C. Connolly, D. C. Goff, and D. C. Henderson
Clozapine-Associated Reduction in Arrest Rates of Psychotic Patients With Criminal Histories
Am J Psychiatry,
February 1, 2001;
158(2):
270 - 274.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Comorbid Substance Abuse and Schizophrenia
Journal Watch Psychiatry,
March 1, 2000;
2000(301):
6 - 6.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|